Oak View, CA, United States of America

Sienna Yoast

This inventor holds 2 USPTO granted patents. Top assignee: Dako Denmark A/s. Active years: 2012-2013.


% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sienna Yoast: Innovator in Cancer Diagnosis

Introduction

Sienna Yoast is a notable inventor based in Oak View, California. She has made significant contributions to the field of cancer diagnosis, particularly through her work on Human Papilloma Virus (HPV) probes. With a total of 2 patents, her innovations are paving the way for improved detection methods in oncology.

Latest Patents

Sienna's latest patents focus on the development of methods for detecting cervical cancer and other types of cancer. One of her inventions involves a composition that utilizes a combination of at least three genomic clones or fragments of high-risk Human Papilloma Virus. This innovative approach aims to enhance the accuracy and efficiency of cancer diagnosis, providing a valuable tool for medical professionals.

Career Highlights

Sienna is currently employed at Dako Denmark A/S, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving diagnostic techniques and contributing to the broader field of cancer research.

Collaborations

Sienna collaborates with talented individuals such as Miu Fun Chau and Kirsten Bisgaard-Franzen. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.

Conclusion

Sienna Yoast's contributions to cancer diagnosis through her innovative patents demonstrate her dedication to advancing medical technology. Her work not only reflects her expertise but also has the potential to significantly impact patient care in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…